Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact
Author:
Publisher
Oxford University Press (OUP)
Subject
General Medicine
Link
http://academic.oup.com/ajcp/article-pdf/137/6/946/4993892/ajcpath137-0946.pdf
Reference46 articles.
1. Performance Characteristics of Different Modalities for Diagnosis of Suspected Lung Cancer*
2. Johnston WW . Percutaneous fine needle aspiration biopsy of the lung: a study of 1,015 patients. Acta Cytol. 1984;28:218–224.
3. Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
4. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
5. The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CORROBORATION OF FINE NEEDLE ASPIRATION CYTOLOGY FINDINGS WITH CELL BLOCK STUDY OF MALIGNANT LUNG LESIONS USING IMMUNOSTAINS (TTF1, NAPSIN A, P40 AND CHROMOGRANIN A).;GLOBAL JOURNAL FOR RESEARCH ANALYSIS;2022-01-15
2. Percutaneous core needle biopsy in the diagnosis of lung lesions: An experience on 280 consecutive cases from a university hospital in southern India;Lung India;2021
3. Cluster Analysis According to Immunohistochemistry is a Robust Tool for Non–Small Cell Lung Cancer and Reveals a Distinct, Immune Signature-defined Subgroup;Applied Immunohistochemistry & Molecular Morphology;2020-04
4. TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit;Diagnostics;2020-01-06
5. Cancer of the Respiratory and Intrathoracic Organs;Cancer Rehabilitation;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3